Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029638319> ?p ?o ?g. }
- W2029638319 endingPage "1409" @default.
- W2029638319 startingPage "1398" @default.
- W2029638319 abstract "The molecular modeling of the phosphotyrosine (pTyr)-SH2 domain interaction in the Stat3:Stat3 dimerization, combined with in silico structural analysis of the Stat3 dimerization disruptor, S3I-201, has furnished a diverse set of analogs. We present evidence from in vitro biochemical and biophysical studies that the structural analog, S3I-201.1066 directly interacts with Stat3 or the SH2 domain, with an affinity (K(D)) of 2.74microM, and disrupts the binding of Stat3 to the cognate pTyr-peptide, GpYLPQTV-NH(2), with an IC(50) of 23microM. Moreover, S3I-201.1066 selectively blocks the association of Stat3 with the epidermal growth factor receptor (EGFR), and inhibits Stat3 tyrosine phosphorylation and nuclear translocation in EGF-stimulated mouse fibroblasts. In cancer cells that harbor aberrant Stat3 activity, S3I-201.1066 inhibits constitutive Stat3 DNA-binding and transcriptional activities. By contrast, S3I-201.1066 has no effect on Src activation or the EGFR-mediated activation of the Erk1/2(MAPK) pathway. S3I-201.1066 selectively suppresses the viability, survival, and malignant transformation of the human breast and pancreatic cancer lines and the v-Src-transformed mouse fibroblasts harboring persistently active Stat3. Treatment with S3I-201.1066 of malignant cells harboring aberrantly active Stat3 down-regulated the expression of c-Myc, Bcl-xL, Survivin, the matrix metalloproteinase 9, and VEGF. The in vivo administration of S3I-201.1066-induced significant antitumor response in mouse models of human breast cancer, which correlates with the inhibition of constitutively active Stat3 and the suppression of known Stat3-regulated genes. Our studies identify a novel small-molecule that binds with a high affinity to Stat3, blocks Stat3 activation and function, and thereby induces antitumor response in human breast tumor xenografts harboring persistently active Stat3." @default.
- W2029638319 created "2016-06-24" @default.
- W2029638319 creator A5015620665 @default.
- W2029638319 creator A5033946508 @default.
- W2029638319 creator A5037938281 @default.
- W2029638319 creator A5061809819 @default.
- W2029638319 creator A5079071054 @default.
- W2029638319 creator A5087339928 @default.
- W2029638319 date "2010-05-01" @default.
- W2029638319 modified "2023-10-18" @default.
- W2029638319 title "A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processes" @default.
- W2029638319 cites W1548640328 @default.
- W2029638319 cites W1563819414 @default.
- W2029638319 cites W1601667381 @default.
- W2029638319 cites W1936787907 @default.
- W2029638319 cites W1943783753 @default.
- W2029638319 cites W1967663251 @default.
- W2029638319 cites W1977532256 @default.
- W2029638319 cites W1977681992 @default.
- W2029638319 cites W1980480652 @default.
- W2029638319 cites W1983570300 @default.
- W2029638319 cites W2004029306 @default.
- W2029638319 cites W2007840001 @default.
- W2029638319 cites W2007897471 @default.
- W2029638319 cites W2011240616 @default.
- W2029638319 cites W2011468046 @default.
- W2029638319 cites W2019299732 @default.
- W2029638319 cites W2024282024 @default.
- W2029638319 cites W2032674547 @default.
- W2029638319 cites W2034808546 @default.
- W2029638319 cites W2043803403 @default.
- W2029638319 cites W2050456292 @default.
- W2029638319 cites W2052892367 @default.
- W2029638319 cites W2053257742 @default.
- W2029638319 cites W2056961869 @default.
- W2029638319 cites W2058792197 @default.
- W2029638319 cites W2062222985 @default.
- W2029638319 cites W2069657245 @default.
- W2029638319 cites W2078144380 @default.
- W2029638319 cites W2078881821 @default.
- W2029638319 cites W2085007453 @default.
- W2029638319 cites W2086307485 @default.
- W2029638319 cites W2087410725 @default.
- W2029638319 cites W2088236771 @default.
- W2029638319 cites W2093750998 @default.
- W2029638319 cites W2094455441 @default.
- W2029638319 cites W2107631090 @default.
- W2029638319 cites W2114464348 @default.
- W2029638319 cites W2117347104 @default.
- W2029638319 cites W2118310862 @default.
- W2029638319 cites W2132047377 @default.
- W2029638319 cites W2132633540 @default.
- W2029638319 cites W2137648328 @default.
- W2029638319 cites W2139520473 @default.
- W2029638319 cites W2160620760 @default.
- W2029638319 cites W2160770127 @default.
- W2029638319 cites W2165296235 @default.
- W2029638319 cites W2170090299 @default.
- W2029638319 cites W2170189698 @default.
- W2029638319 cites W2330829715 @default.
- W2029638319 cites W2799941631 @default.
- W2029638319 cites W4234560968 @default.
- W2029638319 doi "https://doi.org/10.1016/j.bcp.2010.01.001" @default.
- W2029638319 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3188443" @default.
- W2029638319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20067773" @default.
- W2029638319 hasPublicationYear "2010" @default.
- W2029638319 type Work @default.
- W2029638319 sameAs 2029638319 @default.
- W2029638319 citedByCount "162" @default.
- W2029638319 countsByYear W20296383192012 @default.
- W2029638319 countsByYear W20296383192013 @default.
- W2029638319 countsByYear W20296383192014 @default.
- W2029638319 countsByYear W20296383192015 @default.
- W2029638319 countsByYear W20296383192016 @default.
- W2029638319 countsByYear W20296383192017 @default.
- W2029638319 countsByYear W20296383192018 @default.
- W2029638319 countsByYear W20296383192019 @default.
- W2029638319 countsByYear W20296383192020 @default.
- W2029638319 countsByYear W20296383192021 @default.
- W2029638319 countsByYear W20296383192022 @default.
- W2029638319 countsByYear W20296383192023 @default.
- W2029638319 crossrefType "journal-article" @default.
- W2029638319 hasAuthorship W2029638319A5015620665 @default.
- W2029638319 hasAuthorship W2029638319A5033946508 @default.
- W2029638319 hasAuthorship W2029638319A5037938281 @default.
- W2029638319 hasAuthorship W2029638319A5061809819 @default.
- W2029638319 hasAuthorship W2029638319A5079071054 @default.
- W2029638319 hasAuthorship W2029638319A5087339928 @default.
- W2029638319 hasBestOaLocation W20296383192 @default.
- W2029638319 hasConcept C108636557 @default.
- W2029638319 hasConcept C11960822 @default.
- W2029638319 hasConcept C185592680 @default.
- W2029638319 hasConcept C197153747 @default.
- W2029638319 hasConcept C2778923194 @default.
- W2029638319 hasConcept C502942594 @default.
- W2029638319 hasConcept C86803240 @default.
- W2029638319 hasConcept C95444343 @default.
- W2029638319 hasConceptScore W2029638319C108636557 @default.